Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

A century after insulin's discovery, millions still can't access it. On World Diabetes Day 2026, the WHO released its first-ever guidelines for diagnosing and managing type 1 diabetes in adults — covering insulin dosing, blood glucose monitoring, and care across all settings. The recommendations are designed to work in low-resource and humanitarian environments too.
More than 100 years after insulin was discovered, the World Health Organization has finally issued its first-ever guidelines for the diagnosis and management of type 1 diabetes in adults. Released on World Diabetes Day 2026, the recommendations are built to work across every setting — from well-equipped hospitals to low-resource and humanitarian environments — where access to care is often severely limited.
The guidelines call for multiple daily insulin injections with doses adjusted to blood glucose levels, with human insulin flagged as an effective and accessible option. For monitoring, WHO recommends regular blood glucose checks — via finger-prick tests or continuous glucose monitors — and notes that urine glucose testing can serve as a fallback where blood testing isn't available. The guidelines also support WHO's 2030 target of universal access to affordable insulin and glucose self-monitoring.
By the Numbers:
Why it matters: Type 1 diabetes is a survival condition — without insulin, it's fatal. These guidelines give countries, especially those with limited resources, a concrete, evidence-based roadmap to improve care and close the access gap that has persisted for over a century.